Osteoblasts are an important component of the hematopoietic microenvironment in bone. However, the mechanisms by which osteoblasts control hematopoiesis remain unknown. We show that augmented HIF signaling in osteoprogenitors results in HSC niche expansion associated with selective expansion of the erythroid lineage. Increased red blood cell production occurred in an EPO-dependent manner with increased EPO expression in bone and suppressed EPO expression in the kidney. In contrast, inactivation of HIF in osteoprogenitors reduced EPO expression in bone. Importantly, augmented HIF activity in osteoprogenitors protected mice from stress-induced anemia. Pharmacologic or genetic inhibition of prolyl hydroxylases1/2/3 in osteoprogenitors elevated EPO expression in bone and increased hematocrit. These data reveal an unexpected role for osteoblasts in the production of EPO and modulation of erythropoiesis. Furthermore, these studies demonstrate a molecular role for osteoblastic PHD/VHL/HIF signaling that can be targeted to elevate both HSCs and erythroid progenitors in the local hematopoietic microenvironment.

The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO / Rankin, Eb; Wu, C; Khatri, R; Wilson, Tls; Andersen, R; Araldi, E; Rankin, Al; Yuan, J; Kuo, Cj; Schipani, E; Giaccia, Aj. - In: CELL. - ISSN 0092-8674. - 149:1(2012), pp. 63-74. [10.1016/j.cell.2012.01.051]

The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO

Araldi E;
2012-01-01

Abstract

Osteoblasts are an important component of the hematopoietic microenvironment in bone. However, the mechanisms by which osteoblasts control hematopoiesis remain unknown. We show that augmented HIF signaling in osteoprogenitors results in HSC niche expansion associated with selective expansion of the erythroid lineage. Increased red blood cell production occurred in an EPO-dependent manner with increased EPO expression in bone and suppressed EPO expression in the kidney. In contrast, inactivation of HIF in osteoprogenitors reduced EPO expression in bone. Importantly, augmented HIF activity in osteoprogenitors protected mice from stress-induced anemia. Pharmacologic or genetic inhibition of prolyl hydroxylases1/2/3 in osteoprogenitors elevated EPO expression in bone and increased hematocrit. These data reveal an unexpected role for osteoblasts in the production of EPO and modulation of erythropoiesis. Furthermore, these studies demonstrate a molecular role for osteoblastic PHD/VHL/HIF signaling that can be targeted to elevate both HSCs and erythroid progenitors in the local hematopoietic microenvironment.
2012
The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO / Rankin, Eb; Wu, C; Khatri, R; Wilson, Tls; Andersen, R; Araldi, E; Rankin, Al; Yuan, J; Kuo, Cj; Schipani, E; Giaccia, Aj. - In: CELL. - ISSN 0092-8674. - 149:1(2012), pp. 63-74. [10.1016/j.cell.2012.01.051]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2951957
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 239
  • ???jsp.display-item.citation.isi??? 223
social impact